loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2010_259___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Hospira, Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HOSPIRA BOULDER, INC. Boulder US (1)

    filter

    01 Oxaliplatin (1)

    filter

    01 U.S.A (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    HOSPIRA BOULDER, INC. Boulder US

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Oxaliplatin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2010-259 - Rev 00
    Withdrawn by Holder
    Chemical
    2016-12-20
    2019-07-30
    2017
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-259 - Rev 00 of Hospira Boulder, Inc. Boulder Us

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-259 - Rev 00 of Hospira Boulder, Inc. Boulder Us 1

    20

    Hospira Boulder, Inc. Boulder Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Oxaliplatin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2010-259 - Rev 00

    This Chemical Type CEP, issued on December 20, 2016, remains in force until July 30, 2019, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2017 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY